celecoxib/diacerein / Cadila - LARVOL DELTA

Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (clinicaltrials.gov) - P2; N=27; Active, not recruiting; Sponsor: City of Hope Medical Center; Trial primary completion date: Apr 2016 ➔ Jul 2018

Trial primary completion date • Biosimilar • Oncology • Ovarian Cancer